logene

Logene is a synthetic biology company specializing in the design and production of custom genetic circuits and biological systems for research and industrial applications. Founded in 2013, the company leverages advanced computational tools and molecular engineering to enable precise control over biological processes. Its core focus lies in developing standardized genetic parts and biobricks, which are modular DNA sequences that can be combined to create novel biological functions.

The company’s platform integrates computational design with experimental validation, allowing researchers to engineer organisms with tailored behaviors. Logene’s offerings include custom gene synthesis, cloning, and the assembly of complex genetic constructs, often used in synthetic biology, metabolic engineering, and biotechnology. Their services cater to academic institutions, pharmaceutical companies, and biotech startups seeking innovative solutions for drug discovery, biofuel production, and environmental applications.

Logene’s approach emphasizes reproducibility and scalability, ensuring that engineered biological systems perform consistently across different environments. The company has contributed to open-source projects, such as the iGEM competition, by providing resources and tools to advance synthetic biology education and research. While primarily a service provider, Logene also collaborates with clients to develop proprietary biological solutions for specific industrial challenges.

Based in the United States, Logene operates with a focus on quality and innovation, aiming to bridge the gap between theoretical genetic design and practical biological implementation. Its work supports broader advancements in biotechnology, including the development of synthetic organisms for sustainable manufacturing and medical applications.